A detailed history of Voleon Capital Management LP transactions in Moderna, Inc. stock. As of the latest transaction made, Voleon Capital Management LP holds 10,118 shares of MRNA stock, worth $250,521. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,118
Holding current value
$250,521
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$23.51 - $34.67 $237,874 - $350,791
10,118 New
10,118 $261 Million
Q1 2025

May 15, 2025

BUY
$28.35 - $47.53 $1.21 Million - $2.02 Million
42,507 New
42,507 $1.21 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Voleon Capital Management LP Portfolio

Follow Voleon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Voleon Capital Management LP with notifications on news.